Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001170333 | SCV001332904 | likely benign | Cardiomyopathy | 2018-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001593306 | SCV001824088 | likely benign | not provided | 2019-11-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002067839 | SCV002415794 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339422 | SCV002638178 | likely benign | Cardiovascular phenotype | 2022-04-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004545099 | SCV004792007 | likely benign | TTN-related disorder | 2022-09-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |